Clarus Ventures LLC - 02142 Cambridge, MA

Business Name: Clarus Ventures LLC
Categorized In:
Address: 101 Main St # 17, Cambridge, MA 02142
Phone Number: (617) 949-2200
Contact Person: Robert Liptak, Partner
Website Address: clarusventures.com
NAICS Code: 5312100
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2005
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $2.500.000 to $4.999.999
Share This Business:
Similar Businesses: Il Pharma Inc - Cambridge, MA 02142
Newco Ls13 - Cambridge, MA 02142
Sanofi Us Services Inc - Cambridge, MA 02142
Shape Pharmaceuticals Inc - Cambridge, MA 02142
Verastem Inc - Cambridge, MA 02142
Targanta Therapeutics Corporation - Cambridge, MA 02142
Edimer Pharmaceuticals - Cambridge, MA 02142
Eleven Biotherapeutics - Cambridge, MA 02142
Constellation Pharmaceuticals - Cambridge, MA 02142
Millennium Pharmaceuticals - Cambridge, MA 02142
Aegerion Pharmaceuticals Inc - Cambridge, MA 02142
Via Cord LLC - Cambridge, MA 02142
Lipomed Inc - Cambridge, MA 02142
Ironwood Pharmaceuticals Inc - Cambridge, MA 02142
Momenta Pharmaceuticals Inc - Cambridge, MA 02142
Alnylam Pharmaceuticals Inc - Cambridge, MA 02142
Sarepta Therapeutics Inc - Cambridge, MA 02142
Zalicus Inc - Cambridge, MA 02142
Gloucester Pharmaceuticals Inc - Cambridge, MA 02142
Akanas Therapeutics Inc - Cambridge, MA 02142

Clarus Ventures LLC provides professional from its single location at the coordinates 42.362023,-71.082404.

The company offers BOTH variables under the SIC code 2834 and NAICS code 5312100, while making an annual revenue of $2.500.000 to $4.999.999 and hiring a total of 1 to 4 employees.

Founded in 2005, the company can now be visited at 101 Main St # 17, Cambridge, Massachusetts 02142 or contacted through representative Robert Liptak, Partner at (617) 949-2200.

For frequently asked questions and further inquiries about professional , get to know more about Clarus Ventures LLC through its company website at clarusventures.com. Engage with this business on its social media platforms through on Twitter and on Facebook.